UNSPSC 51101653: Fumagillin

This classification denotes an antineoplastic antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7OW73204U1. European Medicines Agency schedules Fumagillin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB23269. Fumagillin generally arises in the molecular formula C26H34O7. The term FUMAGILLIN is an International Non-Proprietary Name or INN. FUMAGILLIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix.

Most nations schedule fumagillin under HS 29419000 and SITC 54139. As of Q4 2014, FUMAGILLIN remains the US FDA Preferred Term for this commodity. Fumagillin bears US NLM identifiers UMLS ID C0060819 and NCI Concept Code C75963. SMILES: O1C(C2C3(OC3)CCC(OC(=O)/C=C/C=C/C=C/C=C/C(=O)O)C2OC)(C1C/C=C(/C)C)C.

UNSPSC 51101653 Fumagillin is a Commodity code, but the recent state and local opportunities tagged under it do not align with fumagillin procurement — they reflect acquisitions of naloxone, drug deactivation systems, medical and first aid supplies, and generic pharmaceuticals through various distribution channels. The code shows no recent activity directly related to fumagillin, an antimicrobial pharmaceutical typically used in veterinary or agricultural contexts. State and local agencies are instead using this code designation for broader pharmaceutical, medical supply, and pharmacy benefit program solicitations that fall outside fumagillin's nominal scope.

Recent opportunities reflect a mix of issuing bodies: a county health department (Seminole County, Florida) procuring naloxone and drug deactivation systems; a municipal fire department (City of Tampa) sourcing medical and first aid supplies; a state health commission (Texas HHS) conducting market research on direct-to-manufacturer prescription programs; and a multistate cooperative purchasing alliance (Minnesota MMCAP, serving state and local participants including Oregon) establishing generic pharmaceutical and OTC product contracts. Geographic activity includes Florida, Texas, Minnesota, and Oregon. Representative recent solicitations include Seminole County's IFB 60459723LAS (naloxone and drug deactivation systems, 1,900 and 800 units annually, due July 26, 2023), Tampa's ITB 26P00145 (medical and first aid supplies for the Fire Department Rescue Division, 169 line items, estimated contract value $700,000, with SLBE set-aside and 5 percent bid discount, due March 13, 2026), and MMCAP's RFP S1070000015802 (generic multi-source pharmaceuticals and OTC products through authorized wholesalers, proposals due March 26, 2026, effective July 1, 2026). The Texas HHS RFI HHS0017013 (posted April 3, 2026) represents exploratory procurement for direct-to-manufacturer prescription fulfillment capabilities. The code's recent tagging does not support meaningful tracking of fumagillin-specific demand.